Efficacy of Tranexamic acid in Melasma
Not Applicable
- Conditions
- Health Condition 1: L811- Chloasma
- Registration Number
- CTRI/2022/12/047814
- Lead Sponsor
- AIIMS JODHPUR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All melasma patients with bilateral symmetrical melasma are included
Exclusion Criteria
Irregular menstruation
Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of topical Tranexamic acid will be assessed compared to normal saline using modified MASI scoreTimepoint: At 4 weeks, 8 weeks, 12 weeks
- Secondary Outcome Measures
Name Time Method Side effects, change in mMASI,Physician Global AssesmentTimepoint: 4 weeks, 8 weeks, 12 weeks